Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

HEME Degradation Enzyme Biliverdin IXb Reductase Is Required for Stem Cell Glutamine Metabolism

Zongdong Li, PhD, Wadie F. Bahou, MD

Blood (2017) 130 (Supplement 1): 3763.

https://doi.org/10.1182/blood.V130.Suppl_1.3763.3763

Published: 2017

Journal Articles

Free Heme Induces a Heme Importer, Heme Catabolism and an Angiogenic Factor in Multiple Organs in Mice: Implications for Organ-Specific Response to Intravascular Hemolysis

Oluwabukola Gbotosho, BSc, MSc, PhD, Maria G Kapetanaki, PhD, Yu Lin, Frances Weidert, MSc, Solomon Fiifi Ofori-Acquah, PhD, Gregory J. Kato, MD

Blood (2017) 130 (Supplement 1): 3468.

https://doi.org/10.1182/blood.V130.Suppl_1.3468.3468

Published: 2017

Journal Articles

BLVRB redox mutation defines heme degradation in a metabolic pathway of enhanced thrombopoiesis in humans

Song Wu, Zongdong Li, Dmitri V. Gnatenko, Beibei Zhang, Lu Zhao, Lisa E. Malone, Nedialka Markova, Timothy J. Mantle, Natasha M. Nesbitt, Wadie F. Bahou

Blood (2016) 128 (5): 699–709.

https://doi.org/10.1182/blood-2016-02-696997

Published: 2016

Includes: Supplemental data

Journal Articles

Altered Heme-Mediated Modulation of Dendritic Cell Function in Sickle Cell Alloimmunization

Emmanuelle Godefroy, PhD, Yunfeng Liu, PhD, Patricia A Shi, MD, W. Beau Mitchell, MD, Devin Cohen, BSc, Stella T. Chou, MD, Deepa Manwani, MD, Karina Yazdanbakhsh, PhD

Blood (2015) 126 (23): 655.

https://doi.org/10.1182/blood.V126.23.655.655

Published: 2015

Journal Articles

Blvrb Mutation Induces Thrombocytosis Via Redox Dysregulation in the Heme Degradation Pathway

Song Wu, PhD, Zongdong Li, PhD, Dmitri V Gnatenko, PhD, BeiBei Zhang, Lu Zhao, Lisa Malone, Nedialka Markova, PhD, Timothy Mantle, PhD, Natasha Nesbitt, PhD, Wadie F. Bahou, MD

Blood (2015) 126 (23): 74.

https://doi.org/10.1182/blood.V126.23.74.74

Published: 2015

Journal Articles

Bilirubin Directly Inhibits Proteolytic Cleavage of a Fluorogenic VWF73 Peptide and Plasma Von Willebrand Factor

Ruinan Lu, MD, PhD, X. Long Zheng, MD, PhD

Blood (2014) 124 (21): 2882.

https://doi.org/10.1182/blood.V124.21.2882.2882

Published: 2014

Journal Articles

Hematoidin

Kenneth Hennrick, David Yang

Blood (2014) 124 (13): 2158.

https://doi.org/10.1182/blood-2013-10-462804

Published: 2014

Journal Articles

Safety and Tolerability Of MP4CO: A Dose Escalation Study In Stable Patients With Sickle Cell Disease

Jo Howard, MB, BChir, MRCP, FRCPath, Swee Lay Thein, MBBS, DSc, Frederic Galacteros, MD PhD, Adlette Inati, MD, Marvin Reid, PhD, Peter E. Keipert, PhD, Tania N. Small, MD, Frank Booth, MA MSc BM BCh FACS

Blood (2013) 122 (21): 2205.

https://doi.org/10.1182/blood.V122.21.2205.2205

Published: 2013

Journal Articles

Clinical Impact Of The Hemoglobin-Scavenging Mechanism In Sickle Cell Disease

Kim R Quimby, MBBS, MSc, Stephen Moe, MBBS, SACC, Ian Sealy, RCIS, CCT, Christopher Nicholls, MBBS, MRCP, Ian R Hambleton, PhD, R Clive Landis, PhD

Blood (2013) 122 (21): 2247.

https://doi.org/10.1182/blood.V122.21.2247.2247

Published: 2013

Journal Articles

H-Ferritin Ferroxidase Activity Induces Cytoprotective Pathways and Inhibits Microvascular Stasis in Transgenic Sickle Mice

Gregory M Vercellotti, MD, Chunsheng Chen, PhD, Carol M Bruzzone, MS, Heather A. Bechtel, MD, Julia Ngyuen, BS, Robert P Hebbel, MD, Clifford J Steer, MD, John D Belcher, PhD

Blood (2012) 120 (21): 378.

https://doi.org/10.1182/blood.V120.21.378.378

Published: 2012

Journal Articles

HMOX1 Is a Targeted Therapy for Myeloma-Induced Bone Disease.

Xin Li, PhD, Wen Ling, MS, Sharmin Khan, MS, Sathisha Upparahalli Venkateshaiah, PhD, Rakesh Bam, Bart Barlogie, MD, PhD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD

Blood (2012) 120 (21): 2944.

https://doi.org/10.1182/blood.V120.21.2944.2944

Published: 2012

Journal Articles

Up-Regulation of Heme Oxygenase-1 Is Induced by the Leukemia Stroma-Cell Interaction and Rescues Acute Myeloid Leukaemia (AML) Cells From Cytarabin Induced Cell Death

Cornelia A. Brendel, MD, Xiaonan Wang, Katharina Henkenius, Mihaela Pali, M.A., Torsten Haferlach, MD, Thorsten Stiewe, MD, Andreas Neubauer, MD

Blood (2012) 120 (21): 533.

https://doi.org/10.1182/blood.V120.21.533.533

Published: 2012

Journal Articles

Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells

Daniele Tibullo, Cesarina Giallongo, Ignazio Barbagallo, Piera La Cava, Nunziatina Parrinello, Giovanni Li Volti, Sr., Giuseppe A Palumbo, Concetta Conticello, MD, Francesco Di Raimondo

Blood (2012) 120 (21): 5005.

https://doi.org/10.1182/blood.V120.21.5005.5005

Published: 2012

Journal Articles

MP4CO, a Pegylated Hemoglobin Saturated with Carbon Monoxide, Inhibits Microvascular Stasis in Transgenic Sickle Mice Through Heme Oxygenase-1.

John D Belcher, PhD, Chunsheng Chen, PhD, Mark Young, PhD, Kenneth Burhop, PhD, Gregory M Vercellotti, MD

Blood (2012) 120 (21): 2112.

https://doi.org/10.1182/blood.V120.21.2112.2112

Published: 2012

Journal Articles

Prevention of Venular Stasis, Circulatory Collapse and Mortality in Transgenic Sickle Mice Administered MP4CO, a Pegylated Hemoglobin Saturated with Carbon Monoxide

John D Belcher, PhD, Chunsheng Chen, PhD, Mark Young, PhD, Phuc Tran, Gregory M Vercellotti, MD

Blood (2011) 118 (21): 850.

https://doi.org/10.1182/blood.V118.21.850.850

Published: 2011

Journal Articles

A Genetic Variation in the Heme Oxygenase-1 Gene Predicts the Outcome of HLA-Fully-Matched Unrelated Bone Marrow Transplantation

Eriko Morishita, MD, PhD, Keiko Maruyama, Akiyoshi Takami, MD PhD, Makoto Onizuka, MD, PhD, Takakazu Kawase, MD, PhD, Yasuo Morishima, MD, PhD, Takahiro Fukuda, MD, Yoshihisa Kodera, MD, PhD, Shigeki Ohtake, MD, PhD, Akihiro Yachie, MD, PhD, Shinji Nakao, MD, PhD

Blood (2011) 118 (21): 1976.

https://doi.org/10.1182/blood.V118.21.1976.1976

Published: 2011

Journal Articles

Heme and the Vasculature: How the Endothelium Protects Itself Against Toxic Iron

Gregory M. Vercellotti, MD, John D Belcher, Ph.D.

Blood (2010) 116 (21): SCI-25.

https://doi.org/10.1182/blood.V116.21.SCI-25.SCI-25

Published: 2010

Journal Articles

Curcumin Down-Regulates Cytokine-Mediated Tissue Factor and Plasminogen Activator Type 1 Expression In Human Endothelial Cells

Eriko Morishita, MD, PhD, Keiko Maruyama, Hidesaku Asakura, MD, PhD, Shigeki Ohtake, MD, PhD, Akihiro Yachie, MD, PhD, Shinji Nakao, MD, PhD

Blood (2010) 116 (21): 3333.

https://doi.org/10.1182/blood.V116.21.3333.3333

Published: 2010

Journal Articles

Mechanisms of Heme Oxygenase 1-Induced Resistance to Imatinib In CML Cells.

Daniele Tibullo, Ignazio Barbagallo, Antonio Branca, Cesarina Giallongo, Piera La Cava, PhD, Nunziatina Parrinello, Giovanni Li Volti, Angelo Vanella, Fabio Stagno, MD, Giuseppe A Palumbo, MD, Francesco Di Raimondo

Blood (2010) 116 (21): 3385.

https://doi.org/10.1182/blood.V116.21.3385.3385

Published: 2010

Journal Articles

OXIDATIVE STRESS MODULATES HEME LEVELS and INDUCES PEROXIREDOXIN-2 IN β THALASSEMIC ERYTHROPOIESIS as NOVEL CYTOPROTECTIVE RESPONSE

Lucia De Franceschi, MD, Mariarita Bertoldi, Maria Domenica Cappellini, MD, Luigia De Falco, PhD, Sara Santos Franco, PhD, Luisa Ronzoni, PhD, Francesco Turrini, PhD, Alessandra Colancecco, Clara Camaschella, MD, Achille Iolascon

Blood (2010) 116 (21): 4266.

https://doi.org/10.1182/blood.V116.21.4266.4266

Published: 2010

NARROW

HEME Degradation Enzyme Biliverdin IXb Reductase Is Required for Stem Cell Glutamine Metabolism

Free Heme Induces a Heme Importer, Heme Catabolism and an Angiogenic Factor in Multiple Organs in Mice: Implications for Organ-Specific Response to Intravascular Hemolysis

BLVRB redox mutation defines heme degradation in a metabolic pathway of enhanced thrombopoiesis in humans

Altered Heme-Mediated Modulation of Dendritic Cell Function in Sickle Cell Alloimmunization

Blvrb Mutation Induces Thrombocytosis Via Redox Dysregulation in the Heme Degradation Pathway

Bilirubin Directly Inhibits Proteolytic Cleavage of a Fluorogenic VWF73 Peptide and Plasma Von Willebrand Factor

Hematoidin

Safety and Tolerability Of MP4CO: A Dose Escalation Study In Stable Patients With Sickle Cell Disease

Clinical Impact Of The Hemoglobin-Scavenging Mechanism In Sickle Cell Disease

H-Ferritin Ferroxidase Activity Induces Cytoprotective Pathways and Inhibits Microvascular Stasis in Transgenic Sickle Mice

HMOX1 Is a Targeted Therapy for Myeloma-Induced Bone Disease.

Up-Regulation of Heme Oxygenase-1 Is Induced by the Leukemia Stroma-Cell Interaction and Rescues Acute Myeloid Leukaemia (AML) Cells From Cytarabin Induced Cell Death

Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells

MP4CO, a Pegylated Hemoglobin Saturated with Carbon Monoxide, Inhibits Microvascular Stasis in Transgenic Sickle Mice Through Heme Oxygenase-1.

Prevention of Venular Stasis, Circulatory Collapse and Mortality in Transgenic Sickle Mice Administered MP4CO, a Pegylated Hemoglobin Saturated with Carbon Monoxide

A Genetic Variation in the Heme Oxygenase-1 Gene Predicts the Outcome of HLA-Fully-Matched Unrelated Bone Marrow Transplantation

Heme and the Vasculature: How the Endothelium Protects Itself Against Toxic Iron

Curcumin Down-Regulates Cytokine-Mediated Tissue Factor and Plasminogen Activator Type 1 Expression In Human Endothelial Cells

Mechanisms of Heme Oxygenase 1-Induced Resistance to Imatinib In CML Cells.

OXIDATIVE STRESS MODULATES HEME LEVELS and INDUCES PEROXIREDOXIN-2 IN β THALASSEMIC ERYTHROPOIESIS as NOVEL CYTOPROTECTIVE RESPONSE

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only